Swedencare Ab · OMXSTO:SECARE
Swedencare Ab — Q1 2026 Earnings Presentation
8 slides from Swedencare Ab's earnings presentation, 2026
Slide 1: Pre Q1 2026 update
Pre Q1 2026 update PRESENTATION WILL BEGIN SHORTLY
Slide 2: Pre Q1 2026 update
Pre Q1 2026 update with Håkan Lagerberg, CEO Jenny Graflind, CFO
Slide 3: Agenda & highlights
Agenda & highlights • Pre-close webinar – purpose and expectations • Follow up from Q4 & update by segment • Financial • Geopolitical & Pet Market update
Slide 4: Profitability hit Q4
Profitability hit Q4 Higher marketing costs on Amazon related to transition of NaturVet and brand protection – will still have some impact in H1 ERP implementation – caused interruptions and affected GM and volumes – no impact going forward Marketing spend to support Big Box-partners, primarily Walm
Slide 5: North America, Europe, Production
North America Eu ro p e Production • Online • Online Strong start • Pharma Strong sales and m ultiple new Strong dem and and finally EU 8 • EU product launches – However still Am azon run internally • UK lower ROI on N aturVet on Am azon – still effect on H1 • Pet Retail • US supplements solid howev
Slide 6: Financial comments
Financial comments • Organic growth – Double digit • Gross margin – Improved margin compared to Q4 and 2025 (56,8% in Q4, 58,1% in 2025) • EBITDA – Improved profitability compared to Q4 (15,9% in Q4, 19,0% in 2025) • No material one-offs are expected • Expo intensive quarter, as always in Q1 • Posit
Slide 7: Chronic Pain Vet Summit CE Event at VMX
Chronic Pain Vet Summit CE Event at VMX
Slide 8: Thank you for participating!
Thank you for participating! Q&A